Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Leases (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Current Leases for 11 consecutive years, with $8.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 9.47% year-over-year to $8.4 million, compared with a TTM value of $8.4 million through Dec 2025, up 9.47%, and an annual FY2025 reading of $8.4 million, up 9.47% over the prior year.
  • Current Leases was $8.4 million for Q4 2025 at Wave Life Sciences, roughly flat from $8.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $8.4 million in Q3 2025 and bottomed at $3.8 million in Q1 2021.
  • Average Current Leases over 5 years is $6.2 million, with a median of $6.4 million recorded in 2023.
  • The sharpest move saw Current Leases soared 44.05% in 2023, then rose 9.47% in 2025.
  • Year by year, Current Leases stood at $5.0 million in 2021, then grew by 10.78% to $5.5 million in 2022, then grew by 22.16% to $6.7 million in 2023, then increased by 13.76% to $7.6 million in 2024, then grew by 9.47% to $8.4 million in 2025.
  • Business Quant data shows Current Leases for WVE at $8.4 million in Q4 2025, $8.4 million in Q3 2025, and $8.1 million in Q2 2025.